Hernando Revilla, S., Herrán Martínez, E., Figuiero-Silva, J., Pedraz Muñoz, J. L., Igartua Olaechea, M., Carro, E., & Hernández Martín, R. M. (2017). Intranasal administration of TAT conjugated lipid nanocarriers loading GDNF for Parkinson’s disease.
Chicago Style CitationHernando Revilla, Sara, Enara Herrán Martínez, Joana Figuiero-Silva, José Luis Pedraz Muñoz, Manuela Igartua Olaechea, Eva Carro, and Rosa María Hernández Martín. Intranasal Administration of TAT Conjugated Lipid Nanocarriers Loading GDNF for Parkinson’s Disease. 2017.
MLA CitationHernando Revilla, Sara, et al. Intranasal Administration of TAT Conjugated Lipid Nanocarriers Loading GDNF for Parkinson’s Disease. 2017.
Warning: These citations may not always be 100% accurate.